Let’s Break It Down,” emphasize the urgent need to remove barriers to prevention, testing, and treatment to reduce liver cancer and eliminate hepatitis by 2030.

Viral diseases called hepatitis B and C primarily target the liver and often incubate quietly for decades before any symptoms ...

In a pair of articles published in Lancet Gastroenterology & Hepatology, scientists lay out the case for why we should expand ...

A study just published on Eurosurveillance has found evidence of substantial lifetime exposure to hepatitis B and C viruses in Ukraine in a 2021 nationwide, representative sample of the population, ...

Discover a study comparing HBV- and alcohol-related ACLF, highlighting distinct clinical profiles and the need for aetiology-specific treatment strategies.

TherVacB, a novel therapeutic vaccine for chronic hepatitis B developed under the leadership of Helmholtz Munich, has entered its first clinical trial in patients. Following a successful phase 1a ...

We read with great interest the recent article by Tseng et al evaluating hepatitis B surface antigen (HBsAg) levels as a ...

Hepatitis remains an important cause of liver disease in Malaysia, although our goal is to eventually eliminate it.

The Determine Antenatal Care Panel is used for the simultaneous detection of infectious diseases that threaten maternal and pediatric health.

Hepatitis Outbreak In India: The monsoon in India brings with it the scope of hepatitis B infection; know everything about its vaccine.

HHS Secretary Robert F. Kennedy Jr. and the CDC vaccine panel have been casting doubt on the hepatitis B shot and the practice of vaccinating newborns.